Literature DB >> 25955341

Everolimus-induced posterior reversible encephalopathy syndrome and bilateral optic neuropathy after kidney transplantation.

Sara Touhami1, Nadia Arzouk, Adil Darugar, Emmanuel Heron, Frederic Clarençon, Bahram Bodaghi, Phuc LeHoang, Benoit Barrou, Valerie Touitou.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25955341     DOI: 10.1097/TP.0000000000000551

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  5 in total

Review 1.  Neurologic Complications of Commonly Used Drugs in the Hospital Setting.

Authors:  Elliot T Dawson; Sara E Hocker
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

2.  Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitors.

Authors:  Eunhae Shin; Dong Hui Lim; Jisang Han; Do-Hyun Nam; Keunchil Park; Myung-Ju Ahn; Won Ki Kang; Jeeyun Lee; Jin Seok Ahn; Se-Hoon Lee; Jong-Mu Sun; Hyun Ae Jung; Tae-Young Chung
Journal:  BMC Ophthalmol       Date:  2020-01-09       Impact factor: 2.209

Review 3.  Immunosuppression-related neurological disorders in kidney transplantation.

Authors:  Irene Faravelli; Daniele Velardo; Manuel Alfredo Podestà; Claudio Ponticelli
Journal:  J Nephrol       Date:  2021-01-22       Impact factor: 3.902

Review 4.  The interplay of autophagy and oxidative stress in the pathogenesis and therapy of retinal degenerative diseases.

Authors:  Kun-Che Chang; Pei-Feng Liu; Chia-Hsuan Chang; Ying-Cheng Lin; Yen-Ju Chen; Chih-Wen Shu
Journal:  Cell Biosci       Date:  2022-01-03       Impact factor: 7.133

5.  An Unusual Presentation of Posterior Reversible Encephalopathy Syndrome Following Liver Transplantation.

Authors:  Akila Rajakumar; Susan Paulin; Dinesh Devarajan; Dinesh Jothimani; Shubha Subramanian; Srinivasan Kalyanasundaram; Mohamed Rela
Journal:  Transplant Direct       Date:  2022-01-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.